Trial NCT02109445

View at ClinicalTrials.gov 
Org. Study IDs: A8641019
Secondary IDs: 2013-005574-21

Last trial update was posted on 2019-01-10

MeSH Interventions

Albumin-Bound Paclitaxel Gemcitabine Nirogacestat Paclitaxel

MeSH Conditions

Adenocarcinoma

Other Conditions

Metastatic Cancer Pancreas

Stopping Reasons

The study was terminated on 24JUN15 due to change in strategy of PF-03084014 development.No safety/efficacy concerns were behind the reason of trial termination

Limitations And Caveats

Due to early termination of the study, only 3 participants were enrolled. Phase 2 was not carried out. As such, there is limited data for Phase 1 and no data for Phase 2.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID